NOTCH1 and B-cell chronic lymphocytic leukemia: On the other hand, targeting the connection between the ligand- and the receptor-presenting cell has emerged as a new therapeutic opportunity that also needs to be explored, in particular for the high-risk NOTCH1-mutated CLL patients.